1. Home
  2. ESPR vs RWT Comparison

ESPR vs RWT Comparison

Compare ESPR & RWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.13

Market Cap

731.9M

Sector

Health Care

ML Signal

HOLD

Logo Redwood Trust Inc.

RWT

Redwood Trust Inc.

HOLD

Current Price

$5.18

Market Cap

707.5M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESPR
RWT
Founded
2008
1994
Country
United States
United States
Employees
N/A
351
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
731.9M
707.5M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ESPR
RWT
Price
$3.13
$5.18
Analyst Decision
Strong Buy
Buy
Analyst Count
4
7
Target Price
$8.75
$6.82
AVG Volume (30 Days)
16.9M
1.1M
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
12.83%
EPS Growth
60.71
N/A
EPS
N/A
N/A
Revenue
$403,135,000.00
N/A
Revenue This Year
N/A
$26.59
Revenue Next Year
$12.81
$22.21
P/E Ratio
N/A
N/A
Revenue Growth
21.31
N/A
52 Week Low
$0.76
$5.00
52 Week High
$4.18
$6.97

Technical Indicators

Market Signals
Indicator
ESPR
RWT
Relative Strength Index (RSI) 70.76 30.04
Support Level $2.37 $5.08
Resistance Level $3.18 $6.00
Average True Range (ATR) 0.05 0.15
MACD 0.07 -0.05
Stochastic Oscillator 96.38 4.38

Price Performance

Historical Comparison
ESPR
RWT

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

About RWT Redwood Trust Inc.

Redwood Trust Inc is a specialty finance company focused on several distinct areas of housing credit. The company delivers customized housing credit investments to a diverse mix of investors through securitization platforms, whole-loan distribution activities, and its publicly traded securities. The company has four reportable segments: Sequoia Mortgage Banking, CoreVest Mortgage Banking, Redwood Investments, and Legacy Investments. Maximum revenue is generated from the Sequoia Mortgage Banking segment, comprising a mortgage loan conduit that acquires residential consumer loans from third-party originators for subsequent sale to whole loan buyers, securitization through its SEMT private-label securitization program, or transfer into its Redwood Investments portfolio.

Share on Social Networks: